Medtronic wanted to partner with surgeons on all aspects of surgery, not just create an enhanced robotic experience. Hugo was designed to respond to surgeons’ wants and needs — like ergonomic comfort ...
Medtronic's Hugo robotic surgery system has been approved in the U.S. for urologic procedures. The company is also a leader ...
Soft tissue robotic systems designed to improve surgical precision are expanding into new specialties and increasing competition for longtime industry leader Intuitive Surgical.
Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic surgical offerings, ultimately creating a connected and integrated operating room today and into the future. GALWAY, ...
First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting Primary safety and effectiveness ...
Add Yahoo as a preferred source to see more of our stories on Google. Medtronic has launched the Embrace Gynecology US investigational device exemption (IDE) study to evaluate the safety and ...
Add Yahoo as a preferred source to see more of our stories on Google. Clinicians view the screen at the console of Medtronic's Hugo surgical robot. Medtronic said Wednesday it has completed the first ...
Medtronic PLC (NYSE:MDT) released on Thursday results from the Enable Hernia Repair clinical study evaluating the performance of the Hugo robotic-assisted surgery (RAS) system in inguinal and ventral ...
Minneapolis-based Medtronic, the world’s largest standalone medical device manufacturer, is developing a new robotic surgical system expected to be released by 2019. Robotically assisted surgery ...
Medical Device Network on MSN
University of Galway opens medtech prototype hub under Medtronic partnership
With financial support from Medtronic, the university’s new hub is intended to drive innovation in the medical device space.
Many people would love to invest in robotic surgery leader Intuitive Surgical, but its shares are rather steeply valued now, with a recent forwardlooking price-to-earnings (P/E) ratio of 54.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results